New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular lithotripsy (IVL) balloon catheters for lesion preparation and stent expansion ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
TCT 1356: A Novel Case of Balloon Valvuloplasty to Rescue a Mechanical Mitral Valve With Frozen Leaflets in a Setting of Cardiogenic Shock Receive the the latest news, research, and presentations from ...
MINNEAPOLIS -- Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. today announced CE (Conformité Européene) mark and launch ...
SIS Medical AG, a Swiss manufacturer of the Super-High-Pressure PTCA balloon catheter (OPN NC), is pleased to announce that the results of the investigator-initiated VICTORY trial were presented ...
Applying precious metals through plating and metallization could help reduce material cost and inspire new possibilities in ...
The new device will be launched worldwide. It follows the introduction of Blue Medical’s CE marked Drug Eluting Balloon Protégé and CoCr Stent on Drug Eluting Balloon Pioneer in March of this year.
CHICAGO — A novel compliant endovascular balloon may have the potential to save lives in patients who experience superior vena cava tears during transvenous lead extraction, researchers reported at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback